151 related articles for article (PubMed ID: 28418887)
1. Metastasis-associated protein 3 in colorectal cancer determines tumor recurrence and prognosis.
Huang Y; Li Y; He F; Wang S; Li Y; Ji G; Liu X; Zhao Q; Li J
Oncotarget; 2017 Jun; 8(23):37164-37171. PubMed ID: 28418887
[TBL] [Abstract][Full Text] [Related]
2. Expression of metastasis-associated protein 3 in human brain glioma related to tumor prognosis.
Shan S; Hui G; Hou F; Shi H; Zhou G; Yan H; Wang L; Liu J
Neurol Sci; 2015 Oct; 36(10):1799-804. PubMed ID: 26002011
[TBL] [Abstract][Full Text] [Related]
3. The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas.
Brüning A; Jückstock J; Blankenstein T; Makovitzky J; Kunze S; Mylonas I
Histol Histopathol; 2010 Nov; 25(11):1447-56. PubMed ID: 20865667
[TBL] [Abstract][Full Text] [Related]
4. NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer.
Li Y; Li Y; Chen W; He F; Tan Z; Zheng J; Wang W; Zhao Q; Li J
Oncotarget; 2015 Sep; 6(29):27641-50. PubMed ID: 26314847
[TBL] [Abstract][Full Text] [Related]
5. MTA3 regulates malignant progression of colorectal cancer through Wnt signaling pathway.
Jiao T; Li Y; Gao T; Zhang Y; Feng M; Liu M; Zhou H; Sun M
Tumour Biol; 2017 Mar; 39(3):1010428317695027. PubMed ID: 28351306
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
7. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
[TBL] [Abstract][Full Text] [Related]
10. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
Zhu J; Chen X; Liao Z; He C; Hu X
Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
[TBL] [Abstract][Full Text] [Related]
11. Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.
Wang G; Wang Q; Fan Y; He X
Am J Cancer Res; 2017; 7(11):2169-2179. PubMed ID: 29218241
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
14. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
[TBL] [Abstract][Full Text] [Related]
15. The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma.
Dong H; Guo H; Xie L; Wang G; Zhong X; Khoury T; Tan D; Zhang H
PLoS One; 2013; 8(5):e62986. PubMed ID: 23671646
[TBL] [Abstract][Full Text] [Related]
16. The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).
Goi T; Nakazawa T; Hirono Y; Yamaguchi A
Oncotarget; 2015 Oct; 6(30):28790-9. PubMed ID: 26318037
[TBL] [Abstract][Full Text] [Related]
17. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
[TBL] [Abstract][Full Text] [Related]
18. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
20. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
